NPI: 1083696710 · MEDINA, OH 44256 · General Acute Care Hospital · NPI assigned 11/17/2005
Authorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
| Authorized Official | LARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER) |
| NPI Enumeration Date | 11/17/2005 |
Other providers sharing the same authorized official: LARAWAY, DENNIS
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,154 | $322K |
| 2019 | 10,266 | $339K |
| 2020 | 6,453 | $324K |
| 2021 | 12,311 | $548K |
| 2022 | 11,716 | $449K |
| 2023 | 109,334 | $3.73M |
| 2024 | 76,181 | $2.32M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11,240 | 9,440 | $1.32M |
| 96361 | Intravenous infusion, hydration; each additional hour | 3,993 | 2,567 | $1.23M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 5,099 | 4,366 | $566K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 7,951 | 3,144 | $504K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 4,240 | 3,889 | $458K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,384 | 1,120 | $328K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,391 | 1,123 | $319K |
| A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | 2,534 | 2,188 | $244K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1,964 | 1,625 | $200K |
| G0378 | Hospital observation service, per hour | 2,285 | 971 | $189K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 295 | 213 | $181K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,473 | 1,076 | $176K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 714 | 552 | $175K |
| A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 1,376 | 1,233 | $165K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,093 | 505 | $164K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 781 | 638 | $136K |
| 80053 | Comprehensive metabolic panel | 16,378 | 12,499 | $111K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 496 | 402 | $91K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,192 | 622 | $83K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 704 | 519 | $69K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 106 | 91 | $69K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 570 | 440 | $66K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,140 | 834 | $61K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 534 | 479 | $58K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 167 | 99 | $43K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 506 | 426 | $40K |
| 71046 | Radiologic examination, chest; 2 views | 1,841 | 1,573 | $31K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1,069 | 494 | $29K |
| 93975 | 262 | 209 | $28K | |
| 82805 | 875 | 659 | $25K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 104 | 81 | $24K |
| 0002A | 587 | 582 | $22K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 14,471 | 11,679 | $22K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,011 | 2,074 | $22K |
| 0001A | 603 | 589 | $21K | |
| 95811 | 30 | 29 | $20K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,398 | 1,035 | $20K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,594 | 1,357 | $20K |
| 76642 | 185 | 137 | $19K | |
| 36415 | Collection of venous blood by venipuncture | 20,387 | 13,879 | $19K |
| 71250 | 238 | 219 | $19K | |
| 97161 | 792 | 658 | $19K | |
| 11043 | 79 | 43 | $19K | |
| A0425 | Ground mileage, per statute mile | 4,268 | 3,613 | $19K |
| 76770 | 114 | 103 | $18K | |
| 73564 | 511 | 462 | $18K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 44 | 37 | $17K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 65 | 40 | $16K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 599 | 540 | $15K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 410 | 383 | $15K |
| 97535 | Self-care/home management training, each 15 minutes | 648 | 427 | $14K |
| 70498 | 42 | 36 | $14K | |
| 80061 | Lipid panel | 1,149 | 998 | $14K |
| 73030 | 494 | 413 | $14K | |
| 86850 | 685 | 564 | $14K | |
| 73630 | 576 | 492 | $13K | |
| 93017 | 147 | 113 | $13K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 624 | 534 | $13K |
| 85027 | 4,527 | 2,765 | $13K | |
| 73130 | 306 | 263 | $12K | |
| 84439 | 579 | 498 | $12K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5,561 | 4,357 | $12K |
| 73502 | 385 | 338 | $11K | |
| J3490 | Unclassified drugs | 252 | 159 | $11K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 736 | 396 | $11K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 36 | 30 | $11K |
| 93971 | 122 | 102 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 755 | 616 | $10K |
| 76830 | Ultrasound, transvaginal | 213 | 168 | $9K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 458 | 206 | $9K |
| 93799 | 1,702 | 563 | $8K | |
| 96367 | 280 | 195 | $8K | |
| 82728 | 565 | 477 | $8K | |
| 87631 | 45 | 44 | $8K | |
| 97116 | 332 | 184 | $8K | |
| 86140 | 636 | 508 | $7K | |
| 86900 | 692 | 570 | $7K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 168 | 163 | $7K |
| 72100 | 257 | 221 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,012 | 805 | $7K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 232 | 179 | $7K |
| 83735 | 4,950 | 3,311 | $6K | |
| 82607 | 465 | 394 | $6K | |
| 73110 | 205 | 183 | $6K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 502 | 414 | $6K |
| 84484 | 4,034 | 2,142 | $6K | |
| 97165 | 175 | 128 | $6K | |
| 73610 | 354 | 305 | $6K | |
| 84702 | 776 | 601 | $6K | |
| 85610 | 2,315 | 1,669 | $5K | |
| 83540 | 624 | 530 | $5K | |
| 76857 | 81 | 66 | $5K | |
| 71045 | Radiologic examination, chest; single view | 1,823 | 1,429 | $4K |
| 83550 | 614 | 525 | $4K | |
| 97162 | 105 | 98 | $4K | |
| 86901 | 693 | 570 | $4K | |
| 82962 | 3,438 | 1,238 | $4K | |
| A9270 | Non-covered item or service | 751 | 285 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 229 | 179 | $4K |
| 98940 | 93 | 61 | $4K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 26 | 24 | $4K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,181 | 3,222 | $3K |
| 97810 | 119 | 76 | $3K | |
| 81001 | 4,083 | 3,205 | $3K | |
| 86803 | 149 | 116 | $3K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 675 | 538 | $3K |
| 70496 | 78 | 65 | $3K | |
| 87077 | 633 | 481 | $3K | |
| 96376 | 1,353 | 682 | $2K | |
| 83880 | 856 | 651 | $2K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 166 | 100 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,296 | 1,516 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 540 | 413 | $2K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 17 | 12 | $2K |
| 86780 | 120 | 99 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,240 | 772 | $2K |
| 87340 | 93 | 68 | $2K | |
| 74018 | 41 | 37 | $1K | |
| 87070 | 376 | 276 | $1K | |
| 85652 | 286 | 226 | $1K | |
| 97811 | 119 | 76 | $1K | |
| 83690 | 2,475 | 1,888 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 89 | 73 | $1K |
| 87186 | 499 | 382 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 67 | 53 | $1K |
| 70486 | 16 | 14 | $1K | |
| 82570 | 121 | 104 | $1K | |
| 82077 | 1,107 | 806 | $1K | |
| 82553 | 61 | 56 | $1K | |
| 80076 | 73 | 56 | $984.05 | |
| 84100 | 372 | 197 | $957.49 | |
| 82784 | 53 | 42 | $880.86 | |
| 82550 | 471 | 366 | $880.45 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 32 | 19 | $831.99 |
| 90715 | 37 | 27 | $770.62 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 300 | 238 | $667.46 |
| 97802 | 13 | 13 | $639.42 | |
| 85730 | 1,276 | 1,007 | $595.83 | |
| 83605 | 1,237 | 822 | $505.75 | |
| 87205 | 350 | 256 | $505.05 | |
| 85379 | 706 | 568 | $497.72 | |
| 82746 | 108 | 83 | $493.83 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,183 | 684 | $488.11 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 104 | 37 | $478.16 |
| 81025 | 1,863 | 1,397 | $419.27 | |
| 85018 | 966 | 727 | $386.34 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,140 | 531 | $381.08 |
| 84132 | 1,095 | 846 | $357.64 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 338 | 305 | $341.13 |
| 99152 | 160 | 121 | $327.02 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 17 | 12 | $307.01 |
| 82043 | 35 | 25 | $260.00 | |
| 87040 | 505 | 367 | $259.38 | |
| 80069 | 27 | 12 | $238.95 | |
| 82375 | 866 | 656 | $229.75 | |
| 00840 | 64 | 42 | $214.92 | |
| 73560 | 14 | 13 | $179.31 | |
| 84703 | 537 | 413 | $161.36 | |
| 81003 | 70 | 54 | $158.79 | |
| 80320 | 13 | 12 | $156.29 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,322 | 2,186 | $123.93 |
| 83050 | 591 | 462 | $111.05 | |
| 84145 | 28 | 25 | $110.01 | |
| 84460 | 31 | 25 | $94.84 | |
| J2704 | Injection, propofol, 10 mg | 2,192 | 1,520 | $92.86 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,803 | 1,934 | $76.35 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 457 | 288 | $62.24 |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,106 | 623 | $61.78 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,775 | 2,471 | $58.65 |
| 91300 | 1,213 | 1,064 | $53.55 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 803 | 450 | $40.49 |
| 00142 | 338 | 244 | $38.90 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,831 | 2,259 | $36.72 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,912 | 2,215 | $28.72 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,167 | 834 | $28.21 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 35 | 27 | $27.40 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 583 | 391 | $21.00 |
| J1790 | Injection, droperidol, up to 5 mg | 254 | 190 | $20.13 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,320 | 909 | $20.02 |
| J7030 | Infusion, normal saline solution , 1000 cc | 84 | 68 | $20.01 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 30 | 15 | $16.02 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 382 | 255 | $15.87 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 82 | 51 | $13.89 |
| J2060 | Injection, lorazepam, 2 mg | 157 | 119 | $9.54 |
| J3480 | Injection, potassium chloride, per 2 meq | 30 | 13 | $8.82 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,599 | 1,111 | $7.23 |
| J1171 | Injection, hydromorphone, 0.1 mg | 45 | 36 | $6.15 |
| 84450 | 14 | 12 | $5.98 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 97 | 57 | $5.74 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 397 | 284 | $4.68 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 23 | 14 | $4.00 |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 383 | 288 | $2.78 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 94 | 86 | $1.23 |
| J1644 | Injection, heparin sodium, per 1000 units | 28 | 14 | $0.78 |
| 94760 | 778 | 392 | $0.00 | |
| J2785 | Injection, regadenoson, 0.1 mg | 40 | 24 | $0.00 |
| 88304 | 171 | 108 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 84 | 79 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 23 | 13 | $0.00 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 353 | 313 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 65 | 40 | $0.00 |
| 80143 | 21 | 13 | $0.00 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 23 | 22 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 29 | 24 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 75 | 59 | $0.00 |
| 80179 | 20 | 12 | $0.00 | |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 15 | 14 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 19 | 12 | $0.00 |